The U.S. Food and Drug Administration (FDA) on Friday issued a notice cautioning against the use of the malaria drugs hydroxychloroquine and chloroquine outside of hospitals and clinical trials, citing the drugs risk of causing abnormal heart rhythms and a dangerously rapid heart rate.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.